Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock Analysis
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a publicly traded company in the HEALTHCARE sector. It trades at $12.65, carries a market capitalization of $4.12B, a price-to-earnings ratio of 34.86. This page summarizes the public market data, fundamentals, and frequently asked questions for AMRX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.
Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC
Exchange: NYSE
Key Metrics
- Price: $12.65
- Market Cap: $4.12B
- P/E Ratio: 34.86
- EPS: $0.37
- 52-Week High: $15.42
- 52-Week Low: $7.07
Market Sentiment
Amneal Pharmaceuticals, Inc. Class A Common Stock currently has a Neutral sentiment score of -0.06.
About Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal Pharmaceuticals, Inc. (AMRX) is a prominent developer and manufacturer focused on delivering high-quality generic and specialty pharmaceuticals across diverse therapeutic areas and dosage forms. Based in Bridgewater, New Jersey, the company utilizes its robust expertise in drug development and operational excellence to provide affordable medication solutions to patients and healthcare providers. With a commitment to innovation and responsiveness to market demands, Amneal is strategical...
GNG Research Analysis
GNG Research scores Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for AMRX.
Frequently Asked Questions
Does AMRX pay dividends?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) does not currently pay a regular dividend.
What is AMRX's P/E ratio?
Amneal Pharmaceuticals, Inc. Class A Common Stock has a price-to-earnings (P/E) ratio of 34.86.
What is AMRX's market cap?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a market capitalization of $4.12B with a current stock price of $12.65.